90% of healthcare startups fail not because their technology doesn't work, but because they run out of capital before generating the clinical data investors need to see. Global Trial Accelerators™ is the clinical trials podcast from bioaccess® — the world's first CRO purpose-built exclusively for first-in-human (FIH) trials — built to help you solve that problem faster, smarter, and at lower cost.
Every episode delivers practical strategies from startup founders, CRO executives, regulatory affairs directors, and healthcare investors. Topics include regulatory pathways across 10+ Latin American countries, ethics approval timelines (4-8 weeks vs. 6-12 months in US/EU), FIH trial design for MedTech, Biopharma, and Radiopharma, patient recruitment strategies with treatment-naive cohorts, and how to generate the clinical milestones that unlock funding rounds and strategic acquisitions.
This podcast is designed for MedTech, Biopharma, and Radiopharma startup founders, regulatory affairs professionals, clinical operations managers, and healthcare investors looking for a competitive edge. Whether you're preparing for your first FIH trial, a mid-stage company seeking faster clinical pathways, or an investor evaluating clinical-stage opportunities, Global Trial Accelerators™ gives you the insider knowledge you need to move faster and make smarter decisions.
New episodes are published weekly, featuring expert interviews, regulatory deep dives, and practical strategy sessions covering FIH clinical trials across Latin America.
Can clinical trials in Latin America really be faster and more affordable?
Yes. Many countries in Latin America offer streamlined ethics committee approvals that can be completed in 4 to 8 weeks compared to 6-12 months in the US or EU. Combined with lower operational costs, startups can reduce overall trial budgets by 30% while maintaining full FDA and EMA compliance.
What types of clinical trials does this podcast cover?
The podcast focuses on first-in-human clinical trials across MedTech (medical devices, diagnostics, digital health), Biopharma (novel therapeutics, biologics, biosimilars), and Radiopharma (radiopharmaceuticals, nuclear medicine). We also explore decentralized trials, AI-driven diagnostics, and theranostics.
Who are the hosts of Global Trial Accelerators™?
The podcast is hosted by Julio G. Martinez-Clark, Co-Founder & CEO of bioaccess®, and Jesús E. Moreno, Business Development Director at bioaccess®. Together they bring over a decade of experience helping MedTech, Biopharma, and Radiopharma startups accelerate first-in-human clinical trials across Latin America.
